Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.
Because of the potential of novobiocin-rifampin for oral therapy of methicillin-resistant Staphylococcus aureus infection, we evaluated the pharmacokinetics of novobiocin and rifampin, alone and in combination, in a randomized, crossover, multiple-dose evaluation (500 mg of novobiocin and 300 mg of...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1986
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176432/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3752982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.1.42 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|